NPS Pharmaceuticals Drug for Rare Bowel Condition Meets Goals in Testing

NPS Pharmaceuticals Inc. said its experimental therapy, Gattex, helped restore normal intestinal function in patients with a rare bowel condition in a study, clearing the way to apply for regulatory approval.
Bloomberg